Oramed Pharmaceuticals Inc
NASDAQ:ORMP

Watchlist Manager
Oramed Pharmaceuticals Inc Logo
Oramed Pharmaceuticals Inc
NASDAQ:ORMP
Watchlist
Price: 2.17 USD 3.83% Market Closed
Market Cap: 88.6m USD

Intrinsic Value

The intrinsic value of one ORMP stock under the Base Case scenario is hidden USD. Compared to the current market price of 2.17 USD, Oramed Pharmaceuticals Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

ORMP Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Oramed Pharmaceuticals Inc

Intrinsic Value History
Dive into the past to invest in the future

ORMP looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether ORMP usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
Compare ORMP to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ORMP?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Oramed Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Oramed Pharmaceuticals Inc

Current Assets 131.5m
Cash & Short-Term Investments 130.6m
Other Current Assets 832k
Non-Current Assets 16.1m
Long-Term Investments 9.5m
PP&E 1m
Other Non-Current Assets 5.5m
Efficiency

Free Cash Flow Analysis
Oramed Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Oramed Pharmaceuticals Inc

Revenue
2m USD
Cost of Revenue
-2m USD
Gross Profit
13k USD
Operating Expenses
-14.3m USD
Operating Income
-14.3m USD
Other Expenses
-13.9m USD
Net Income
-28.2m USD
Fundamental Scores

ORMP Profitability Score
Profitability Due Diligence

Oramed Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

Oramed Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ORMP Solvency Score
Solvency Due Diligence

Oramed Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
hidden
Solvency
Score

Oramed Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ORMP Price Targets Summary
Oramed Pharmaceuticals Inc

Wall Street analysts forecast ORMP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ORMP is 3.32 USD with a low forecast of 3.28 USD and a high forecast of 3.41 USD.

Lowest
Price Target
3.28 USD
51% Upside
Average
Price Target
3.32 USD
53% Upside
Highest
Price Target
3.41 USD
57% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Oramed Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ORMP is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ORMP Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ORMP stock?

The intrinsic value of one ORMP stock under the Base Case scenario is hidden USD.

Is ORMP stock undervalued or overvalued?

Compared to the current market price of 2.17 USD, Oramed Pharmaceuticals Inc is hidden .

Back to Top